Testing a new eye drop for eyelid inflammation caused by tiny mites
Part of Eyes & vision clinical trials.
This trial tests an investigational eye drop (GLK-321) to see if it safely and effectively treats Demodex blepharitis, an eyelid inflammation caused by tiny mites. It may help people who have signs of this condition and good enough vision.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have signs of Demodex blepharitis in at least one eye
- Your vision is 20/80 or better in each eye (with glasses if needed)
- You do not have eczema or dermatitis on or around your eyes
- You have not used any eyelid hygiene products in the past 14 days
- You do not have an active eye infection or inflammation (other than blepharitis)
- You are not pregnant, planning pregnancy, or nursing
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new eye drop treatment for Demodex blepharitis (a mite-related eyelid condition) in people who wear special scleral contact lenses. If you have this condition and wear these lenses, this trial may help reduce your symptoms like redness, itching, and burning.
This trial tests a new eye drop, Drop 0.4%, for people with dry eye. It includes both people who wear contact lenses and those who don’t, to see if the drop is safe and helps with symptoms.
This study tests whether RCI001, a new eye drop treatment, can help people with dry eye disease. If you've had dry eye symptoms for at least 6 months and are interested in trying a new treatment, this trial may be for you.
This study tests different doses of an investigational eye drop (BRM421) to see if it safely helps people with dry eye disease. It may be an option if you have had dry eyes for a while and are looking for a new treatment.
This trial tests a new eye drop called DFL24498 to see if it helps people with dry eye disease. You may qualify if your dry eye is moderate to severe and other treatments haven't worked well for you.
This trial tests a new eye drop called JMKX003948 in healthy volunteers. It checks if the eye drop is safe and how the body handles it.
Hear when a new Demodex Blepharitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.